dc.contributor.author |
Kasimov, Ulugbek K.; Abdullaev, Ulugbek P.; Boboev, Kakhramon X.; and Sultanova, Diyora U. |
|
dc.date.accessioned |
2022-10-12T14:21:39Z |
|
dc.date.available |
2022-10-12T14:21:39Z |
|
dc.date.issued |
2022 |
|
dc.identifier.uri |
http://repository.tma.uz/xmlui/handle/1/3806 |
|
dc.description.abstract |
Humanity faced a new challenge when, in December 2019, severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the cause of
an outbreak of pneumonia cases in Wuhan, a city in the Chinese province of Hubei. In the first few months of 2020, infection with this new coronavirus led to a
global pandemic that affected every country in the world, with more than 21
million cases by August 2020 [1]. Although coronavirus disease 2019 (COVID-19)
primarily presents as a lung infection with symptoms ranging from mild upper
respiratory infection to severe pneumonia and acute respiratory distress syndrome,
other multisystem manifestations of the disease and its associated complications
are increasingly common. |
en_US |
dc.language.iso |
en_US |
en_US |
dc.publisher |
Central Asian Journal of Medicine |
en_US |
dc.relation.ispartofseries |
УДК;100109, |
|
dc.subject |
COVID-19; SARS-CoV-2; invasive mucormycosis; |
en_US |
dc.title |
ANALYSIS OF THE RESULTS OF TREATMENT OF 93 PATIENTS ANALYSIS OF THE RESULTS OF TREATMENT OF 93 PATIENTS WITH POST-COVID THROMBOSES OF THE CAVERNOUS SINUS IN WITH POST-COVID THROMBOSES OF THE CAVERNOUS SINUS IN THE CONDITIONS OF THE DEPARTMENT OF PURULENT THE CONDITIO |
en_US |
dc.type |
Article |
en_US |